Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Lasers Med Sci ; 34(5): 1041-1047, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30565200

RESUMO

To identify the best low level laser photobiomodulation application site at the same irradiation time to increase the viability of the skin flap in rats. Eighteen male rats (Rattus norvegicus: var. Albinus, Rodentia Mammalia) were randomly distributed into three groups (n = 6). Group I (GI) was submitted to simulated laser photobiomodulation; group II (GII) was submitted to laser photobiomodulation at three points in the flap cranial base, and group III (GIII) was submitted to laser photobiomodulation at 12 points distributed along the flap. All groups were irradiated with an Indium, Galium, Aluminum, and Phosphorus diode laser (InGaAlP), 660 nm, with 50 mW power, irradiated for a total time of 240 s in continuous emission mode. The treatment started immediately after performing the cranial base random skin flap (10 × 4 cm2 dimension) and reapplied every 24 h, with a total of five applications. The animals were euthanized after the evaluation of the percentage of necrosis area, and the material was collected for histological analysis on the seventh postoperative day. GII animals presented a statistically significant decrease for the necrosis area when compared to the other groups, and a statistically significant increase in the quantification of collagen when compared to the control. We did not observe a statistical difference between the TGFß and FGF expression in the different groups evaluated. The application of laser photobiomodulation at three points of the flap cranial base was more effective than at 12 points regarding the reduction of necrosis area.


Assuntos
Terapia com Luz de Baixa Intensidade , Pele/efeitos da radiação , Retalhos Cirúrgicos , Sobrevivência de Tecidos/efeitos da radiação , Animais , Núcleo Celular/metabolismo , Núcleo Celular/efeitos da radiação , Colágeno/metabolismo , Fatores de Crescimento de Fibroblastos/metabolismo , Fibroblastos/metabolismo , Fibroblastos/efeitos da radiação , Lasers Semicondutores , Masculino , Necrose , Ratos Wistar , Fator de Crescimento Transformador beta/metabolismo
2.
Lasers Med Sci ; 33(9): 1867-1874, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29790013

RESUMO

Wound healing is a complex biological process with specific phases. Photobiomodulation (PBM) decreases the inflammatory infiltrate, stimulating fibroblast proliferation and angiogenesis, and therefore, is indicated for wound healing. Vitamin A is used to reverse the inhibitory effects on wound healing and accelerate the healthy granulation tissue. The study aimed to evaluate the effect of topical vitamin A and PBM (GaAlAs) in inflammatory phase of cutaneous wounds. Forty Wistar male rats were separated into four groups: (1) control (CG); (2) laser group (LG) GaAlAs, 670 nm, 30 mW, energy per point of 0.9 J, radiating by 1 point in 30 s; (3) vitamin A group (VitAG); and (4) laser group plus vitamin A (LG + VitAG). Wounds were surgically made by a punch biopsy with 10 mm of diameter on the back of the animals and all treatments were started according to the experiment. The treatments were administered for four consecutive days and biopsy was performed on day 4. We performed both H&E and immunohistochemistry analysis. The results were compared between groups by one-way analysis of variance ANOVA test with post hoc Tukey (p < 0.05). Inflammatory infiltrate increased significantly in LG compared to CG and VitAG (p < 0.05). Regarding angiogenesis, VEGF expression was increased significantly in LG and LG + VitAG groups, p < 0.01. The results indicate that proposed treatments were effective on the healing process improved by LG and LG + VitAG. We show that laser plus vitamin A enhances healing by reducing the wound area and may have potential application for clinical management of cutaneous wounds.


Assuntos
Inflamação/patologia , Terapia com Luz de Baixa Intensidade , Vitamina A/farmacologia , Cicatrização/efeitos dos fármacos , Cicatrização/efeitos da radiação , Animais , Biópsia , Ciclo-Oxigenase 2/metabolismo , Imuno-Histoquímica , Lasers Semicondutores , Masculino , Ratos Wistar , Pele/patologia , Fator A de Crescimento do Endotélio Vascular/metabolismo
3.
Braz. j. med. biol. res ; 47(9): 746-752, 09/2014. graf
Artigo em Inglês | LILACS | ID: lil-719312

RESUMO

Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver and is associated with obesity and insulin resistance. Activin A is a member of the transforming growth factor beta (TGF)-β superfamily and inhibits hepatocyte growth. Follistatin antagonizes the biological actions of activin. Exercise is an important therapeutic strategy to reduce the metabolic effects of obesity. We evaluated the pattern of activin A and follistatin liver expression in obese rats subjected to swimming exercise. Control rats (C) and high-fat (HF) diet-fed rats were randomly assigned to a swimming training group (C-Swim and HF-Swim) or a sedentary group (C-Sed and HF-Sed). Activin βA subunit mRNA expression was significantly higher in HF-Swim than in HF-Sed rats. Follistatin mRNA expression was significantly lower in C-Swim and HF-Swim than in either C-Sed or HF-Sed animals. There was no evidence of steatosis or inflammation in C rats. In contrast, in HF animals the severity of steatosis ranged from grade 1 to grade 3. The extent of liver parenchyma damage was less in HF-Swim animals, with the severity of steatosis ranging from grade 0 to grade 1. These data showed that exercise may reduce the deleterious effects of a high-fat diet on the liver, suggesting that the local expression of activin-follistatin may be involved.


Assuntos
Animais , Masculino , Ativinas/metabolismo , Terapia por Exercício , Folistatina/metabolismo , Hepatopatia Gordurosa não Alcoólica/metabolismo , Obesidade/terapia , Esforço Físico , Peso Corporal , Glicemia/análise , Modelos Animais de Doenças , Dieta Hiperlipídica/efeitos adversos , Fígado Gorduroso/metabolismo , Fígado Gorduroso/patologia , Expressão Gênica , Hepatopatia Gordurosa não Alcoólica/terapia , Obesidade/metabolismo , Distribuição Aleatória , Ratos Wistar , RNA Mensageiro/metabolismo , Natação
4.
Braz J Med Biol Res ; 47(9): 746-52, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25075578

RESUMO

Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver and is associated with obesity and insulin resistance. Activin A is a member of the transforming growth factor beta (TGF)-ß superfamily and inhibits hepatocyte growth. Follistatin antagonizes the biological actions of activin. Exercise is an important therapeutic strategy to reduce the metabolic effects of obesity. We evaluated the pattern of activin A and follistatin liver expression in obese rats subjected to swimming exercise. Control rats (C) and high-fat (HF) diet-fed rats were randomly assigned to a swimming training group (C-Swim and HF-Swim) or a sedentary group (C-Sed and HF-Sed). Activin ßA subunit mRNA expression was significantly higher in HF-Swim than in HF-Sed rats. Follistatin mRNA expression was significantly lower in C-Swim and HF-Swim than in either C-Sed or HF-Sed animals. There was no evidence of steatosis or inflammation in C rats. In contrast, in HF animals the severity of steatosis ranged from grade 1 to grade 3. The extent of liver parenchyma damage was less in HF-Swim animals, with the severity of steatosis ranging from grade 0 to grade 1. These data showed that exercise may reduce the deleterious effects of a high-fat diet on the liver, suggesting that the local expression of activin-follistatin may be involved.


Assuntos
Ativinas/metabolismo , Terapia por Exercício , Folistatina/metabolismo , Hepatopatia Gordurosa não Alcoólica/metabolismo , Obesidade/terapia , Esforço Físico , Animais , Glicemia/análise , Peso Corporal , Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Fígado Gorduroso/metabolismo , Fígado Gorduroso/patologia , Expressão Gênica , Masculino , Hepatopatia Gordurosa não Alcoólica/terapia , Obesidade/metabolismo , RNA Mensageiro/metabolismo , Distribuição Aleatória , Ratos Wistar , Natação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA